Suche
Mein Konto
SENSATION: PCI Pharma receives billion-dollar investment for growth!
Kohlberg is investing in PCI Pharma Services with Bain Capital to support growth and sterile manufacturing in the US.
SENSATION: PCI Pharma receives billion-dollar investment for growth!
A HUMP for pharmaceuticals! Today, PCI Pharma Services, a behemoth contract development and manufacturing company (CDMO), brings EARTHQUAKEING news that has the entire industry in turmoil! The spectacular investment, led by the powerful Bain Capital and lead investor Kohlberg, is seen as a strategic masterpiece. But that's NOT ALL! Mubadala Investment Company and Partners Group are also heavily involved in supporting this deal - all without revealing a CENT of the financial details! Newswire reports that PCI is valued at a staggering $10 BILLION, including debt!
Did you know that in recent years PCI has transformed from a timid packaging company into a superhuman full-service CDMO? Since Kohlberg and Mubadala took over in 2020, this colossal company's revenue has doubled and its customer base has even quadrupled! This immense transformation is nothing short of breathtaking! Pharma Manufacturing announces that PCI now boasts more than 30 facilities in North America, Europe and Australia! This is pure madness!
Sensational expansion of capacities!
But wait, that's not all! Investments in this strategy are designed to EXPAND PCI's sterile filling, high potency manufacturing and biologics capabilities. These actions will take pharmaceutical manufacturing and a more robust supply chain infrastructure in the US to new, accelerated levels! Winning the big deal will help strengthen the resilience of US pharmaceuticals and drastically shorten the time to market for complex therapies.
A 50+ year old company with incredible experience is ready to expand its services even further and catapult the customer service experience to unprecedented heights! With over 7,500 employees and 38 locations in seven countries, PCI is more than ready to overcome future challenges and reach new heights! The company's headquarters in Philadelphia is the hotspot for groundbreaking pharmaceutical developments!
The big plan: A billion dollars for the future!
And now things get even more exciting! Building on a massive $1 BILLION investment strategy already underway, PCI has completed the acquisition of Ajinomoto Althea – a key sterile bottling player previously owned by giant Ajinomoto Co.! This mega transaction is just ONE example of PCI's unstoppable growth!
The future looks bright! PCI plans to grow not only organically, but also through strategic acquisitions! With large-scale sterile filling manufacturing facilities coming online this summer in Bedford, New Hampshire, the company will now boast massive production capabilities!
Amid the constant change in the pharmaceutical industry, where structural adjustments are in focus and new economic challenges are looming, PCI Pharma Services shows how to weather the storm! The analysis of the importance of the pharmaceutical industry for overall economic development underlines its role as a key to future prosperity. This is the future of pharmacy, and it's going to be great!
The world will watch in amazement at PCI's developments as the company makes its vision come true while revolutionizing the entire pharmaceutical industry! Are we ready for what is to come?